Refresher Course on Gynaecological Cancers

Chairs:  I. Colombo, CH - A. Pasic, BA

DESCRIPTION

The refresher course on gynaecological cancers has been designed for medical and clinical oncologists with the aim to provide an update on the -state of-the art therapeutic options as well as an overview of the latest advances in the field.
Practical training will be offered in the frame of clinical case presentations, prepared and presented by participants and discussed with the faculty.

Attendance to the course is limited and by application only. Priority will be given to applicants who have attended a previous ESO masterclass.

LEARNING OBJECTIVES

• Update on the latest advances in diagnostic procedure
• Update on the latest advances and on the state-of- the-art treatment options
• Learn about the management of specific situations
• Understand the pathology and molecular characteristics of gynecological cancer
• Learn about the future development in the treatment of gynecological malignancies
• Debate controversies and challenges in gynaecological cancer treatment
• Improve practical skills in multidisciplinary management and follow-up of gynaecological cancer patients

OFFICIAL LANGUAGE

The official language will be English. No translation will be available.

CME ACCREDITATION

An application to the European Accreditation Council for Continuing Medical Education (EACCME) will be submitted to obtain CME credits for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

ESCO - The ESO College

Being selected to take part in this ESO activity gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
This event also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the event earns participants 9 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.

PARTICIPATION

Attendance is limited to 30 participants and admittance is by competitive application only. Priority will be given to applicants who have attended an ESO masterclass.

Applicants should meet the following profile:

• Age between 30 and 45 years
• At least 2-3 years’ experience in medical oncology
• Fluency in English

Successful applicants are granted free registration.

Accommodation at the course venue for arrival on 24^th November and departure on the 26^th November will be provided to participants not residing in the Sarajevo area.

ORGANISING SECRETARIAT

Mariachiara Deleo

European School of Oncology (ESO)
Via Turati 29
IT- 20121 Milan

ph  +39 335 181 4541
email: mdeleo@eso.net

Dolores Knupfer
European School of Oncology (ESO)
Via Vicenzo Vela 6
CH- 6500 Bellinzona

ph +41 91 820 09 52
e-mail: dknupfer@eso.net

APPLICATIONS CLOSED.

APPLICATION 

Interested candidates should apply online providing:

• Application template
• Abstract
• Letter describing motivation for attending
• Short CV (template) with the list of publications (if the list of publication is not provided, it will be assumed that no articles have been published)

If you are a past ESO Masterclass participant, you only need to submit the application template and abstract.

ABSTRACT

Applicants are requested to submit an abstract describing a clinical case related to gynecological cancer on one of the following cathegories:

• Cervical
• Endometrial
• Ovarian

A selected number of admitted participants will have the opportunity to present their clinical case in the format of a clinical grand round discussion with the chairs, other faculty members and participants within plenary tumour board sessions in the programme. The application outcome will be notified by e-mail by the 13^th October.

Andrej Cokan, University Medical Centre Maribor, Gynaecological and Breast Cancer Dpt., Maribor, SI
Ilaria Colombo, Oncology Institute of Southern Switzerland, EOC, Oncology Dpt., Bellinzona, CH
Michael Halaska, Charles University, Dept. of Obstetrics and Gynecology, Prague, CZ
Berisa Hasanbegovic, Clinical Center University of Sarajevo, Oncology Dept., Sarajevo, BA
Ermina Iljazovic, University Clinical Center Tuzla, Dept. of Pathology, Tuzla, BA
Vesna Kesic, University of Belgrade, Clinic for Obstetrics and Gynecology, Clinical Center of Serbia, Belgrade, RS
Anes Pasic, Clinical Center University of Sarajevo, Oncology Dept., Sarajevo, BA
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, IT
Maja Ravnik, University Medical Centre Maribor, Department of Oncology, Maribor, SI
Alina Sturdza, Comprehensive Cancer Center, Medical University of Vienna, Department of Radiation Oncology, Vienna, AT